UTHealth Houston Opens Recruitment in RISE-UP Clinical Drug Trial for People With Sickle Cell Anemia
January 19, 2024
January 19, 2024
HOUSTON, Texas, Jan. 19 -- The University of Texas Health Science Center at Houston issued the following news:
A medication that appeared to stabilize the function and shape of red blood cells in an earlier study for patients with sickle cell disease is now part of a Phase III clinical trial that is open for enrollment at UTHealth Houston.
The trial, led locally by Modupe Idowu, MD, professor of hematology with McGovern Medical School at UTHealth Houston, will enroll pa . . .
A medication that appeared to stabilize the function and shape of red blood cells in an earlier study for patients with sickle cell disease is now part of a Phase III clinical trial that is open for enrollment at UTHealth Houston.
The trial, led locally by Modupe Idowu, MD, professor of hematology with McGovern Medical School at UTHealth Houston, will enroll pa . . .